Penicillin
G Aqueous (Pfizerpen)
Category:
Description:
Indications:
-
Meningococcal
menigitis/septicemia
-
Actinomycosis
-
Clostridial
infections (botulism, gas gangrene and tetanus)
-
Fusopirochetal
infections
-
Rat-bite
fever
-
Listeria
infections
-
Pasteurella
infections
-
Erysipeloid
endocarditis
-
Diphtheria
(adjunct to antitoxin to prevent carrier state)
-
Anthrax
-
Serious
streptococcal infections
-
Syphilis
(neurosyphilis)
-
Disseminated
gonococcal infections
-
Lyme
disease (non-FDA approved indication)
Contraindications:
Precautions:
-
Pregnancy
category B
-
Use
with caution in patients with penicillin or cephalosporin allergy
(5-10% chance of cross-reactivity)
-
Counsel
patient to finish all medication to prevent development of resistance
-
Intramuscular
injection or continuous IV infusion are preferred routes of
administration
-
Dosage
modifications are generally only required in patients with severe
renal impairment
Adverse
Reactions (Side Effects):
|
Dosage:
Administered
by injection (available in powder for injection and premixed/frozen)
-
Meningococcal
menigitis/septicemia:
-
Adult:
24 million units per day (1-2 million units q2h)
-
Adult:
200,000-300,000 units/kg/day q2-4h in divided doses for 24 doses
total
-
Children:
250,000 units/kg/day divided equally q4h for 7-14 days
-
Actinomycosis:
-
Clostridial
infections
-
Fusopirochetal
infections
-
Rat-bite
fever
-
Adult:
12-20 million units/day q4-6h for 3-4 weeks
-
Children:
150,000-250,000 units/kg/day divided equally q4h for 4 weeks
-
Listeria
infections
-
Pasteurella
infections
-
Erysipeloid
endocarditis
-
Diphtheria
-
Adult:
2-3 million units/day q4-6h for 10-12 days
-
Children:
150,000-250,000 units/kg/day divided equally q6h for 7-10 days
-
Anthrax
-
Serious
streptococcal infections
-
Syphilis
-
Disseminated
gonococcal infections
-
Lyme
disease
-
use
oral penicllin V for erythema chronicum migrans
-
200,000-300,000
units/kg/day IV for 10-14 days
|
Home
· Military Medicine
· Sick Call · Basic Exams
· Medical Procedures
· Lab and X-ray · The Pharmacy
· The Library · Equipment
· Patient Transport
· Medical Force
Protection · Operational Safety · Operational
Settings · Special
Operations · Humanitarian
Missions · Instructions/Orders · Other Agencies · Video Gallery
· Forms · Web Links · Acknowledgements
· Help · Feedback Approved for public release;
Distribution is unlimited. The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks.
Source: Operational Medicine 2001, Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300.
Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300 |
Operational Medicine
Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
January 1, 2001 |
United States Special Operations
Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323 |
*This web version is provided by The Brookside Associates, LLC. It contains
original contents from the official US Navy NAVMED P-5139, but has been
reformatted for web access and includes advertising and links that were not
present in the original version. The medical information presented was reviewed and felt to be accurate in 2001. Medical knowledge and practice methods may have changed since that time. Some links may no longer be active. This web version has not been approved by the
Department of the Navy or the Department of Defense. The presence of any
advertising on these pages does not constitute an endorsement of that product or
service by either the US Department of Defense or the Brookside Associates. The
Brookside Associates is a private organization, not affiliated with the United
States Department of Defense.
© 2015, Brookside Associates, LLC. All rights reserved
Other Brookside Products
|
|